Introduction
Reactive oxygen species (ROS) are ubiquitous by-products of aerobic metabolism and comprise a group of free radical and non-radical species, e.g. superoxide, hydrogen peroxide, hydroxyl radical and hypohalous acids, of varying reactivity. Although ROS have a number of defined physiological functions, it is their potentially detrimental effects, specifically on DNA, that are a focus of this chapter. There are numerous instances throughout the scientific literature where the origins of ROS, both endogenous and exogenous, have been described [1] . Similarly, the identities, mechanisms of formation and repair of products of DNA oxidation have recently been comprehensively reviewed [2] .
Conceptually, it is straightforward to appreciate a role for DNA oxidation in the pathogenesis of cancer, for example via the induction of mutations through the miscoding properties of DNA lesions. However, there still seems to be a lack of experimental evidence directly linking DNA oxidation and carcinogenesis. The links between chronic exposure to oxidants and carcinogenesis, of which DNA oxidation is a component, are a little firmer. Certain, initially non-malignant, chronic inflammatory conditions are associated with significant potential to progress to malignancy, and aside from the modulation of gene expression, chronic inflammation is likely to involve elevated production of ROS and increased oxidative damage to DNA. Examples of this scenario include associations between inflammatory bowel diseases, such as ulcerative colitis, Crohn's disease and colorectal cancer; H. pylori infection/gastritis and gastric cancer; chronic gastric reflux and oesophageal cancer; cirrhosis, hepatitis B/C infection and hepatocellular carcinoma. In fact, it would seem that chronic inflammation can drive malignancy in several tissues and elevated levels of DNA oxidation products have been detected in both inflamed and malignant tissue.
It seems that, initially at least, there is a more tenuous link between DNA oxidation and the pathogenesis of non-malignant conditions, despite the fact that markers of oxidative damage to DNA have been measured in many examples of this type of disease. Is it simply that some of these markers serve as convenient, established, Associated with this is more specific damage to mitochondria and the mitochondrial genome, leading to deficits in ATP production with consequences for mitochondrial/nuclear DNA repair and increased production of ROS, ultimately leading to compromised cell function and cell death. An associated factor, related to cell death is the induction of premature senescence in selected cell populations, as there is some evidence that oxidative damage can accelerate telomere shortening [3] .
(ii), The cytotoxic impact of DNA damage may lead to release of cell components into the extracellular medium, this may become important in conditions where damaged material cannot be scavenged effectively, e.g. in autoimmune diseases such systemic lupus erythematosus. (iii), DNA damage may be sufficiently selective that coding regions of expressed genes are specifically damaged, or promoter regions, or 5 epigenetic processes such as DNA methylation are affected leading to alterations in gene expression. The impact of oxidative DNA damage on promoter function, for example, is relatively under-studied yet some more recent studies would suggest that this represents a new dimension to the pathogenic importance of oxidative DNA damage extending beyond mutagenicity [3, 4] . although the interpretation of changes or differences in these levels is not entirely straightforward. This is partly due to the fact that elevated levels in urine or other 6 extracellular matrices, could indicate enhanced oxidative damage to the genome, increased repair of lesions or even contributions from the diet and cell turnover.
Notable progress is being made regarding the interpretation of extracellular levels of 8-OH-dG, with an emerging view that diet and cell turnover may have little role in contributing to urinary 8-OH-dG levels [6] . With this in mind, there are still several potential intracellular sources (repair activities) for this lesion, but if diet and cell turnover can be excluded, this presents an opportunity to re-interpret existing data in light of this new information. Whether these emerging findings are applicable to other urinary lesions derived from oxidative DNA damage (e.g. thymine glycol, 5-hydroxymethyluracil) remains to be fully established [7, 8] . In terms of the sub-cellular sources of lesions, the nucleus, deoxynucleotide pools and mitochondria are logical locations. Mitochondrial DNA would be a particular target of interest largely because, although mitochondria are endowed with their own set of repair enzymes, mitochondrial DNA is more exposed than nuclear DNA and lies close to an important site for potential ROS production. The detrimental impact of damage to mitochondrial DNA is particularly acute in those cells dependent on mitochondrial function, such as neuronal cells or cardiomyocytes, and indeed studies would indicate a role for such damage in the pathogenesis of Alzheimer's disease or heart failure, for example [10] . Figure 1 considers the potential sources of DNA oxidation products.
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As an analytical target, the popularity of 8-OH-dG relies on an abundant literature concerning analysis and biological properties, as well as the importance ascribed by the presence of multiple DNA repair pathways for this lesion. Whether the repair pathways are extensive simply because they have been studied more closely or because this lesion is peculiarly genotoxic is not entirely clear. Certainly, 8-OH-dG has been widely analysed in tissues and extracellular matrices in a number of nonmalignant conditions, although a limited number of studies have examined more than one lesion. Thus, a major focus of this chapter is on 8-OH-dG, simply because of the relatively abundant literature devoted to it, a situation not shared by most of the other lesions resulting from DNA oxidation. In the following sections, we discuss a range of non-malignant conditions and also refer the reader to a recent review article which considers many of the conditions discussed herein and contains numerous literature citations relating to particular diseases [2] .
Autoimmune disease
Inflammation is an important component of the pathology of systemic and tissuespecific autoimmune diseases, e.g. rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis, Sjogren's syndrome, Behcet's disease. The majority of the studies of DNA oxidation in autoimmune disease are confined to RA and SLE, with analysis being conducted predominantly in peripheral blood mononuclear cells (PBMC), with some analysis of urinary 8-OH-dG levels [11, 12] . It is presently difficult to assign exact roles for DNA oxidation in the pathogenesis of these conditions, largely because, beyond using lesion analysis as a biomarker of oxidative stress, studies examining functional impacts of these lesions on immune cell function or to explain damage to affected organ systems are lacking. Those studies that have measured levels of 8-OH-dG, show elevated levels of this lesion in PBMC from patients with RA and SLE (also Behcet's disease and vasculitis), plus depending on the particular study, either very low or unchanged urinary excretion of 8-OH-dG in SLE and elevated excretion of 8-OH-dG in RA, compared to healthy subjects.
Elevated excretion has been taken as indicative of increased oxidative stress in RA while the reports of very low levels of 8-OH-dG in urine from SLE patients has been taken as evidence of abnormal repair of 8-OH-dG, rather than a low level of oxidative damage. Despite this, functional measurements of specific enzyme activities for the repair of oxidative DNA damage in SLE seem to be minimal. Although not specific for oxidative stress, elevated levels of DNA strand breaks, in PBMC from RA patients have also been reported, again the functional significance of this is unclear.
In the case of RA, the hyperplastic tissue in the synovial joint, the pannus, is subject to an oxidative burden which is most likely accompanied by oxidative DNA damage.
Indeed the ability of cells in the pannus to deal with DNA damage may be compromised by evidence of somatic mutations in p53 (transition mutations characteristic of oxidative damage) and potential abnormalities in mismatch repair, the latter accompanied by elevated levels of microsatellite instability. Thus, cell populations in the pannus are presented with opportunities to evade DNA repair and for mutations to be expressed. Collectively, there are several consequences of this for certain cell populations, including increased or decreased cell death, acquisition of growth advantages, or enhancement of a pro-inflammatory environment, since p53 is reported to be involved in controlling the expression of IL-6 for example. The recent demonstration that oxidatively-modified mitochondrial DNA (mtDNA) has proinflammatory properties, and can induce arthritis in a mouse model, coupled with the presence of mtDNA and 8-OH-dG in synovial fluids of RA patients, implies that this material could help perpetuate a pro-inflammatory environment in the RA joint [13] .
Modification of the known autoantigen, the ribonucleoprotein Ro60, in SLE by the lipid peroxidation end product 4-hydroxy-nonenal to enable neo-antigen formation and facilitate epitope spreading, links oxidative stress in this condition directly with the pathology. This apparently intimate involvement of oxidative stress with the pathology in SLE is supported further by reports of mice models, where antioxidants can significantly suppress mortality in the NZB x NZW F1 lupus-prone mouse and a recent report implicating oxidative stress as an early event in the development of lupus-like symptoms in the Nrf2-deficient mouse (Nrf2 is a key transcription factor involved in cellular response to oxidative stress). Oxidative modification of DNA has been shown to render it more immunogenic and also markedly increase its antigenicity for anti-dsDNA antibodies characteristic of SLE [14] . This may provide a mechanism for enhancement of selected autoantigen production which, coupled with reports of elevated apoptosis and/or poor scavenging of apoptotic debris and enhanced oxidative stress in SLE perhaps leading to enhanced cell turnover, provides a route to expose the immune system to oxidatively-modified nucleic acid. Autoantibodies specifically recognising 8-OH-dG, and other lesions (5-hydroxymethyl-2'-deoxyuridine), have been isolated from SLE patients, providing support that oxidatively modified DNA may play a role in this disease [15] . Despite this evidence, the question still remains whether damage is introduced into DNA before or after cell death, either route may be possible in light of suggestions of DNA repair abnormalities in SLE; a direct demonstration of a repair deficit for oxidative DNA damage in SLE-derived neutrophils has been reported.
Neurological disease
Oxidatively damaged DNA has been measured in several neurodegenerative conditions, most notably Parkinson's disease (PD), Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), Friedrich's ataxia (FA), and Huntington's disease (HD) [16, 17] . However, whilst oxidative stress, and more particularly oxidative DNA damage, may be a feature of some neurodegenerative diseases, there A recent report would indicate that the impact of oxidative DNA damage in the brain extends beyond neurodegenerative disease and into that syndrome to which we will all eventually succumb, ageing [4] . At least in the context of neuronal cells, this study suggests that the ageing brain is, perhaps not surprisingly, accompanied by alterations in gene expression. What is interesting is that there may be a specific role for oxidative DNA damage in the down-regulation of selected genes via oxidative 13 modification to promoter regions, which, as well as being more susceptible to damage because of their high GC content are also less likely to be repaired. What makes the promoter regions of particular genes more susceptible to damage compared to others awaits further study. While not all reports in the literature are supportive of a role for oxidative damage in HD, there would seem to be some defects in mitochondrial function, along with evidence of regional specificity in the distribution of oxidative DNA damage to mtDNA in the brain of patients with HD, suggesting such damage may be important [20] .
Cardiovascular disease
Oxidative DNA damage has been analysed primarily in atherosclerosis, in plaque tissue itself, in lymphocytes from patients with atherosclerosis or those at risk for the disease. Whilst many studies support elevated levels of lesions, particularly 8-OH-dG, these lesions have usually been measured in well established disease, thus roles for 15 oxidative DNA damage as an early event in cardiovascular disease (CVD) is not particularly developed. As with the neurodegenerative conditions discussed above, an important target for oxidative DNA damage in CVD would seem to be mitochondria, with death of selected cell populations being an eventual outcome, e.g. in the case of cardiomyocyte injury and heart failure [21] . The mitochondria of ischaemic hearts display abnormalities in oxidative phosphorylation, as well as an increased prevalence of the common 5 kbp deletion in the mitochondrial genome. This deletion also appears more frequently in cells of the atherosclerotic plaque and even in PBMC. It has been suggested that oxidative stress may contribute to this, and other, mtDNA deletion events and its occurrence in PBMC suggests a more global oxidative stress in the vasculature of these patients [22] . The common mtDNA deletion also accumulates suggestions from the literature would indicate that carcinogenesis and atherosclerosis may share common molecular processes, with a potential pathogenic role for DNA damage [23] In this case, this raises the possibility of (oxidative) DNA damage inducing mutation, conferring survival/growth advantages and assisting the clonal expansion of selected vascular smooth muscle cells, for example [24] . This latter area and that of the examination of somatic mutations in CVD, is receiving notable research attention, not to the detriment of the widely accepted inflammation hypothesis of atherosclerosis, but as a complement to this. Oxidative damage to DNA in the pathogenesis of cardiovascular disease evidently extends beyond heart failure and atherosclerosis, having implications for the pathogenesis of stroke, ischaemiareperfusion injury and pre-eclampsia.
Diabetes
In both type 1 and type 2 diabetes there are many reports of elevated oxidative stress, including markers of DNA oxidation (predominantly 8-OH-dG, but some studies have measured oxidised pyrimidines and ring-opened purines), in both extracellular matrices, peripheral blood cells and in rodent models of diabetes. As with many other studies, these lesions have been used primarily markers of oxidative stress. There are close mechanistic links between hyperglycaemia, the oxidative stress seen in this disease and, by implication, oxidative DNA damage. The latter is thought to be involved in the development of several of the important complications of diabetes, e.g. peripheral vascular disease, cardiomyopathy, nephropathy, and renal pathology [25] . The most likely effect of this oxidative DNA damage is a role in induction of cell death, and perhaps negative effects upon gene expression. Of direct relevance to the production of insulin, oxidative DNA damage probably plays a role in the destruction of insulin-secreting pancreatic islet β-cells in both type 1 and type 2 diabetes. Several reports do again imply an important role for mitochondrial damage, not only to the metabolically active β-cells, but also to the tissues integral to the manifestation of diabetic complications, e.g. there are significant correlations between tissue levels of 8-OH-dG and ~5 kbp deletions in mtDNA from muscle of patients with non-insulin dependent diabetes mellitus and in renal tissues of diabetic rats [26] .
Conclusions, DNA Oxidation -biomarker, biohazard … or both?
A pathogenic role for oxidatively-damaged DNA in non-malignant disease is perhaps, for some, difficult to conceive. In part this is because in many conditions where oxidative DNA damage has been measured, little consideration has been given to pathogenic roles for such damage. It is perfectly valid to use measures of oxidative DNA damage as markers of on-going oxidative stress, although the utility of such What is evident to us, is that nuclear DNA is not necessarily the most important target genome, and we also suggest that a viewpoint solely linking oxidative DNA damage with mutation is perhaps naive. The effects of oxidative DNA damage on epigenetic phenomena, and the control of gene expression is, we feel, set to develop over the coming years and provide renewed impetus and relevance to the free radical field. At this stage, our conclusion is perhaps predictable: oxidative DNA damage in nonmalignant conditions can represent both a biohazard and a biomarker. However the extent to which the damage extends beyond being a biomarker to play a role in the pathology, and also the timing of damage in relation to the pathogenesis of the disease, also appears to depend on the condition studied. 
